Tarek Sherif Joins Ryght as Investor and Advisor
Sherif will support Ryght's mission to accelerate clinical trials through advanced AI technology.
Ryght, a healthcare technology provider focused on generative AI for the life sciences industry, has announced that Tarek Sherif, the former co-founder, chairman, and CEO of Medidata Solutions, is joining as an advisor and investor. With his extensive experience and deep understanding of clinical research, Sherif is set to play a crucial role in advancing Ryght's innovative solutions.
Transforming Clinical Trials
Having co-founded Medidata Solutions in 1999, Sherif was instrumental in revolutionizing clinical research through automation and cloud technology. His leadership helped position Medidata as a benchmark in clinical trial data management, ultimately leading to its acquisition by Dassault Systèmes for $5.8 billion in 2019. Today, he holds a significant role as Chairman of the Life Sciences & Healthcare Sector board at Dassault Systèmes, further showcasing his influence in the industry.
The Role of Generative AI
Reflecting on his decision to join Ryght, Sherif remarked that, "Medidata was an innovator in leveraging cloud technology to enhance trial efficiency and deepen analytics-based insights. With advancements in precision medicine and increasing trial complexities, Ryght is uniquely positioned to elevate clinical research methodologies. Their generative AI platform and extensive global research site network streamline and automate many manual processes involved in clinical trials, ultimately accelerating the time it takes to bring life-saving therapies to market."
Building a Stronger Future for Clinical Research
Simon Arkell, Co-founder and CEO of Ryght, expressed enthusiasm at Sherif's addition to the team. He stated, "Tarek's industry knowledge and experience will fundamentally enhance Ryght's position within the life sciences sector. Our dedicated team is committed to creating solutions that not only expedite clinical research but also improve patient outcomes. We are excited to have Tarek on board as we pursue our mission to get critical treatments into the market more efficiently."
About Ryght
Ryght is a dynamic, privately-held healthcare technology company harnessing the power of generative artificial intelligence (GenAI) solutions tailored for the life sciences industry. The company specializes in offering customized solutions designed to streamline clinical trials, optimize workflows for trial sites, sponsors, and professionals in healthcare. By leveraging multiple large language models and vector databases, Ryght enables real-time data analysis, providing actionable insights to biopharma teams while ensuring compliance and data security.
Contact Information
For more inquiries about custom development or partnership discussions, you can reach out to the Ryght team through their official website. They are keen to explore potential collaborations that align with their mission to improve clinical research efficiency.
Frequently Asked Questions
Who is Tarek Sherif?
Tarek Sherif is the co-founder, former chairman, and CEO of Medidata Solutions, who has joined Ryght as an advisor and investor to enhance clinical trials.
What is the mission of Ryght?
Ryght aims to transform clinical trials using advanced generative AI technology to streamline processes and improve patient outcomes.
How did Tarek contribute to Medidata Solutions?
As co-founder, Tarek Sherif played a vital role in automating clinical trials and developing cloud-based solutions, elevating Medidata as a leader in clinical research.
What technologies does Ryght utilize?
Ryght employs generative artificial intelligence and optimizes large language models to handle real-time data and enhance clinical trial workflows.
How can I learn more about Ryght's services?
Interested individuals can visit Ryght's website for detailed information about their innovative solutions and opportunities for collaboration.
